# Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant

> **NCT07634536** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Stanford University** · enrollment: 30 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Myeloproliferative Neoplasm
- Myelodysplastic Syndromes

## Interventions

- **RADIATION:** VMAT-Based Total Marrow and Lymphoid Irradiation (TMLI)
- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide
- **BIOLOGICAL:** Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)
- **DRUG:** Mycophenolate mofetil (MMF)
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT07634536
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11
- **Primary completion:** 2028-08
- **Final completion:** 2028-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07634536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07634536, "Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07634536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*